Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667459 · ClinicalTrials.gov registry record · Phase 3
Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD
A Phase 3 study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- Phase 3
- Development phase
- 280
- Enrollment target
NCT00667459 is a Phase 3 study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 280 participants.
The verdict
NCT00667459, a Phase 3 study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 280 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the safety and effectiveness of the PRESTIGE® LP Cervical Disc as a method of treating patients with symptoms of cervical degenerative disc disease at a single level from C3-C4 to C6-C7.
Interventions
- DEVICE PRESTIGE® LP Cervical Disc
- DEVICE ATLANTIS Anterior Cervical Plate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2005-01 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667459
The ClinicalTrials.gov registry entry for NCT00667459 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PRESTIGE® LP Cervical Disc is the first listed.
NCT00667459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667459 about?
NCT00667459 is a clinical study titled "Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD". The purpose of this clinical trial is to evaluate the safety and effectiveness of the PRESTIGE® LP Cervical Disc as a method of treating patients with symptoms of cervical degenerative disc disease at a single level from C3-C4 to C6-C7.
What is the current status of trial NCT00667459?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 280 participants. The study started on 2005-01. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00667459?
The interventions under investigation include: PRESTIGE® LP Cervical Disc (DEVICE), ATLANTIS Anterior Cervical Plate (DEVICE).
Who is sponsoring clinical trial NCT00667459?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.